- Companies
- Dr. Squatch
Dr. Squatch Acquisition, Valuation, Funding & Investors
Dr. Squatch was acquired by Unilever for $1.5B in June 2025, a 16.7x multiple on $90M of revenue.
Dr. Squatch revenue at acquisition
$90M
Last twelve months · Jun 2025
Dr. Squatch revenue multiple at acquisition
16.7x
EV/Revenue · Jun 2025
Key investors in Dr. Squatch
Summit Partners
About Dr. Squatch
Dr. Squatch is a Los Angeles-based men's grooming brand manufacturing natural personal care products since 2013. The lineup includes bar soaps, deodorants, toothpaste, shampoos, conditioners, and colognes using 98-100% natural ingredients free of phthalates, parabens, and SLS. Signature scents feature Pine Tar, Grapefruit IPA, and Bay Rum, with themed bundles tied to franchises, sold via direct subscriptions, e-commerce, and retailers like Target.
Founded
2013
HQ
Website
Status
Acquired
Customer focus
B2C
Revenue model
Subscription
Revenue
$90M (Jun 2025)
Valuation
$1.5B (acquired Jun 2025)
Dr. Squatch Acquisition
Dr. Squatch was acquired by Unilever for $1.5B on 23 June 2025.
The acquisition price implies a 16.7x revenue multiple on $90M of revenue.
Dr. Squatch, founded in 2013, produces natural, high-performance men's personal care products including soaps, body washes, deodorants, hair care, skin care, and grooming items with unique scents, sold via direct-to-consumer, e-commerce, retail channels like Walmart, and subscriptions primarily in North America and Europe. The brand has achieved over $400 million in annual sales, captured 8% U.S. market share in bar soap and skin/body care, surpassed Unilever's Axe in skin/body care sales from 2023-2024, and built a loyal Gen Z male following through viral social media marketing, influencer partnerships, and celebrity collaborations like Sydney Sweeney. Unilever, a CPG giant, acquired Dr. Squatch from growth equity firm Summit Partners in a deal announced in June 2025, reportedly valued at $1.5 billion though official terms undisclosed, with closure expected later that year pending regulatory approvals. Unilever's strategic rationale centers on expanding its portfolio into premium, high-growth men's personal care amid a category that grew 31% to nearly $6 billion in the U.S. from 2018-2023, leveraging Dr. Squatch's DTC model for first-party data, digital engagement, and omnichannel presence to scale internationally beyond the U.S. The acquisition aligns with Unilever CEO Fernando Fernandez's plan to allocate 50% of ad spend to social media and expand influencer partnerships 20-fold, positioning Dr. Squatch to complement existing offerings and drive regimen expansion. Dr. Squatch CEO Josh Friedman highlighted amplifying the brand's mission to inspire healthier men globally under Unilever, while Unilever Personal Care President Fabian Garcia praised its clever strategies for international growth. The deal reflects broader DTC men's grooming consolidation, following Unilever's $1 billion Dollar Shave Club purchase in 2016 and contrasting FTC-blocked Harry's acquisition, with Dr. Squatch's prior $2 billion exit pursuit at $90 million EBITDA underscoring its 20% margins and cultural relevance in a competitive landscape.
| Acquirer | Date | Type | Price | EV/Revenue |
|---|---|---|---|---|
| 23 Jun 2025 | Strategic M&A | $1.5B | 16.7x |
Dr. Squatch Funding History
Dr. Squatch has raised 1 funding round.
| Date | Stage | Investors | Deal Summary |
|---|---|---|---|
| Jan 2021 | Undisclosed stage | Summit Partners | Summit Partners invested in Dr. Squatch in 2021, when the Los Angeles-area natural men's soap and personal care brand was still founder-led. Dr. Squatch sells natural cold-process bar soap, body wash, deodorant, hair care, lip balm and cologne through direct-to-consumer and retail channels. Summit managing director Christopher Dean served as chairman of the board. Summit held the investment until June 2025, when Unilever agreed to acquire the brand from it. Financial terms of the original investment were not disclosed. The brand's hero products include natural cold-process bar soap, body wash, deodorant, hair care, lip balm and cologne, and it is headquartered in Marina del Rey, California. Reports in June 2025 put the Unilever price at about USD 1.5 billion, which Unilever did not confirm. |
Who has invested in Dr. Squatch?
1 investor has backed Dr. Squatch across its funding rounds, including Summit Partners.
Dr. Squatch Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Dr. Squatch investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialDr. Squatch Competitors
Dr. Squatch competitors include listed companies like Suning.com, DeNA, E-MART and Sailvan Times, and private ones like Pharmapacks and Lush Fresh Handmade Cosmetics.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $250M | - | $1.1B | 4.4x | ||
| Publicly listed | $7.3B | $899M | $1.5B | 0.6x | ||
| Publicly listed | $934M | $174M | $1.5B | 1.1x | ||
| Publicly listed | $21B | $1.7B | $1.5B | 0.5x | ||
| Private | - | - | $1.5B | - | ||
| Publicly listed | $1.8B | $87M | $1.6B | 0.7x |
Dr. Squatch Public Comps
Dr. Squatch is no longer listed, but its public comps include Suning.com, DeNA, E-MART, Intercos, Zydus Wellness, Sailvan Times, Harbin Fuerjia Technology, Honasa Consumer, Amorepacific Group and Jamieson Wellness.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $7.3B | $899M | 0.6x | 0.6x | 5.1x | 18.2x | |||
| $934M | $174M | 1.1x | 1.1x | 5.9x | 6.7x | |||
| $21B | $1.7B | 0.5x | 0.5x | 6.4x | 8.7x | |||
| $1.2B | $155M | 1.3x | 1.3x | 10.2x | 8.7x | |||
| $419M | $50M | 4.5x | 3.7x | 37.6x | 26.7x | |||
| $1.8B | $87M | 0.8x | 0.7x | 16.6x | 12.9x | |||
| $284M | $92M | 3.7x | 3.1x | 11.5x | 11.0x | |||
| $254M | $27M | 6.1x | 5.4x | 58.0x | 46.9x | |||
This data is available for Pro users. Sign up to see all Dr. Squatch competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Dr. Squatch
| When was Dr. Squatch founded? | Dr. Squatch was founded in 2013. |
| Where is Dr. Squatch headquartered? | Dr. Squatch is headquartered in Los Angeles, CA, United States. |
| Is Dr. Squatch publicly listed? | No, Dr. Squatch was acquired by Unilever in June 2025. |
| Who acquired Dr. Squatch? | Dr. Squatch was acquired by Unilever in June 2025. |
| How much was Dr. Squatch acquired for? | Dr. Squatch was acquired for $1.5B in June 2025, a 16.7x revenue multiple. |
| What was Dr. Squatch's last funding round? | Dr. Squatch's last funding round was a undisclosed-stage round in January 2021. |
| Who are Dr. Squatch's investors? | Dr. Squatch's investors include Summit Partners. |
| Which companies are comparable to Dr. Squatch? | Companies comparable to Dr. Squatch include Pharmapacks, Suning.com, DeNA, E-MART, Lush Fresh Handmade Cosmetics and Sailvan Times. |
See companies similar to Dr. Squatch
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




